CCL5 induces a pro-inflammatory profile in microglia in vitro

Cellular Immunology

Volumn 270, Issue 2, 2011, Pages 164-171

  Škuljec, Jelena ^a,b   Sun, Hui ^a,b   Pul, Refik ^a   Bénardais, Karelle ^a,b   Ragancokova, Daniela ^a,b,c   Moharregh Khiabani, Darius ^a   Kotsiari, Alexandra ^a   Trebst, Corinna ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

CCL2; CCL3; CCL5; Chemokines; CXCL1; Immunomodulation; Microglia

Indexed keywords

BETA ACTIN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; NITRIC OXIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL5; CHEMOKINE CXCL1; CHEMOTAXIS; DNA PRIMERS; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-10; MICROGLIA; NITRIC OXIDE; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR1; RECEPTORS, INTERLEUKIN-8B; RECOMBINANT PROTEINS; RNA, MESSENGER;

RATTUS;

EID: 80051671298     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.05.001     Document Type: Article

References (45)

1. Boven L.A., van Meurs M., van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., Laman J.D. Myelin-laden macrophages are anti-inflammatory consistent with foam cells in multiple sclerosis. Brain 2006, 129:517-526.
2. Garden G.A., Moller T. Microglia biology in health and disease. J. Neuroimmune. Pharmacol. 2006, 1:127-137.
3. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Rev. 2005, 48:16-42.
4. Bajetto A., Bonavia R., Barbero S., Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 2002, 82:1311-1329.
5. Rezaie P., Trillo-Pazos G., Everall I.P., Male D.K. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75.
6. Luan J., Furuta Y., Du J., Richmond A. Developmental expression of two CXC chemokines, MIP-2 and KC and their receptors. Cytokine 2001, 14:253-263.
7. Asensio V.C., Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 1999, 22:504-512.
8. Callewaere C., Banisadr G., Rostene W., Parsadaniantz S.M. Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J. Mol. Endocrinol. 2007, 38:355-363.
9. Xia M.Q., Qin S.X., Wu L.J., Mackay C.R., Hyman B.T. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. Pathol. 1998, 153:31-37.
10. Xia M., Qin S., McNamara M., Mackay C., Hyman B.T. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am. J. Pathol. 1997, 150:1267-1274.
11. Szczucinski A., Losy J. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol. Scand. 2007, 115:137-146.
12. Filipovic R., Jakovcevski I., Zecevic N. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev. Neurosci. 2003, 25:279-290.
13. Trebst C., Konig F., Ransohoff R.M., Brück W., Stangel M. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions. Mult. Scler. 2008, 14:728-733.
14. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999, 103:807-815.
15. Biber K., Zuurman M.W., Dijkstra I.M., Boddeke H.W. Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2002, 2:63-68.
16. Gamo K., Kiryu-Seo S., Konishi H., Aoki S., Matsushima K., Wada K., Kiyama H. G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J. Neurosci. 2008, 28:11980-11988.
17. Chiu K., Yeung S.C., So K.F., Chang R.C. Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma. Cell Mol. Immunol. 2010, 7:61-68.
18. McMahon E.J., Cook D.N., Suzuki K., Matsushima G.K. Absence of macrophage-inflammatory protein-1α delays central nervous system demyelination in the presence of an intact blood-brain barrier. J. Immunol. 2001, 167:2964-2971.
19. Izikson L., Klein R.S., Charo I.F., Weiner H.L., Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 2000, 192:1075-1080.
20. Carlson T., Kroenke M., Rao P., Lane T.E., Segal B. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 2008, 205:811-823.
21. Rankine E.L., Hughes P.M., Botham M.S., Perry V.H., Felton L.M. Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur. J. Neurosci. 2006, 24:77-86.
22. Perrin F.E., Lacroix S., viles-Trigueros M., David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 2005, 128:854-866.
23. Villalta F., Zhang Y., Bibb K.E., Kappes J.C., Lima M.F. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect. Immun. 1998, 66:4690-4695.
24. Jiang Y., Beller D.I., Frendl G., Graves D.T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 1992, 148:2423-2428.
25. Stangel M., Joly E., Scolding N.J., Compston D.A. Normal polyclonal immunoglobulins ('IVIg') inhibit microglial phagocytosis in vitro. J. Neuroimmunol. 2000, 106:137-144.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
27. Grosskreutz J., Haastert K., Dewil M., Van D.P., Callewaert G., Robberecht W., Dengler R., van Den B.L. Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. Cell Calcium 2007, 42:59-69.
28. Maysami S., Nguyen D., Zobel F., Heine S., Hopfner M., Stangel M. Oligodendrocyte precursor cells express a functional chemokine receptor CCR3: implications for myelination. J. Neuroimmunol. 2006, 178:17-23.
29. Stangel M., Compston A. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors. J. Neuroimmunol. 2001, 112:63-71.
30. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 1994, 205:1907-1915.
31. Pang Y., Campbell L., Zheng B., Fan L., Cai Z., Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 2010, 166:464-475.
32. Blanpain C., Doranz B.J., Bondue A., Govaerts C., De L.A., Vassart G., Doms R.W., Proudfoot A., Parmentier M. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 2003, 278:5179-5187.
33. Tian Y., New D.C., Yung L.Y., Allen R.A., Slocombe P.M., Twomey B.M., Lee M.M., Wong Y.H. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of G-alpha 14-coupled pathways. Eur. J. Immunol. 2004, 34:785-795.
34. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., Peterson P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17:942-964.
35. Taub D.D., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol. 1996, 156:2095-2103.
36. Qiu L., Ding L., Huang J., Wang D., Zhang J., Guo B. Induction of copper/zinc-superoxide dismutase by CCL5/CCR5 activation causes tumour necrosis factor-alpha and reactive oxygen species production in macrophages. Immunology 2009, 128:e325-e334.
37. Taub D.D., Ortaldo J.R., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukoc. Biol. 1996, 59:81-89.
38. Carson M.J., Bilousova T.V., Puntambekar S.S., Melchior B., Doose J.M., Ethell I.M. A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics. 2007, 4:571-579.
39. Huang W.C., Lin Y.S., Wang C.Y., Tsai C.C., Tseng H.C., Chen C.L., Lu P.J., Chen P.S., Qian L., Hong J.S., Lin C.F. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 2009, 128:e275-e286.
40. Aberg D. Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. Endocr. Dev. 2010, 17:63-76.
41. Seimi S.K., Seinosuke K., Tsuyoshi S., Tomomi U., Tetsuaki H., Miki K., Ryuji T., Kenji I., Mitsuhiro Y. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1. Circ. J. 2004, 68:247-253.
42. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993, 72:415-425.
43. van Veen T., Nielsen J., Berkhof J., Barkhof F., Kamphorst W., Bo L., Ravid R., Verweij C.L., Huitinga I., Polman C.H., Uitdehaag B.M. CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis. J. Neuroimmunol. 2007, 190:157-164.
44. Trebst C., Staugaitis S.M., Tucky B., Wei T., Suzuki K., Aldape K.D., Pardo C.A., Troncoso J., Lassmann H., Ransohoff R.M. Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol. Appl. Neurobiol. 2003, 29:584-595.
45. Eltayeb S., Berg A.L., Lassmann H., Wallstrom E., Nilsson M., Olsson T., Ericsson-Dahlstrand A., Sunnemark D., expression Temporal, CCR1 cellular origin of CC chemokine receptors CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J. Neuroinflammation 2007, 4:14.